Please assess the completion status of the following clinical trial:

Trial Title: Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic Rickets

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosed as primary hypophosphatemic rickets based on familial history, genetic test or laboratory test results.~Exclusion Criteria:~* A hyperparathyroidism

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: 14 Years
- Healthy Volunteers: f

Study Arms:
- Z-521 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).